Mechanisms of mitochondrial microRNA regulation in cardiovascular diseases

Mech Ageing Dev. 2023 Jun:212:111822. doi: 10.1016/j.mad.2023.111822. Epub 2023 May 12.

Abstract

In the past years, microRNAs (miRNAs) have emerged as important biomarkers and essential regulators of many pathophysiological processes. Several studies have focused on the importance of these noncoding RNAs (ncRNAs) in maintaining mitochondrial function, introducing the term mitochondrial microRNAs (mitomiRs) to refer to those miRNAs controlling mitochondrial activity, either by targeting cytoplasmatic messenger RNAs (mRNAs) or by acting inside the mitochondria. Mitochondrial homeostasis is paramount in the cardiovascular system, where an important energy supply is needed to maintain the homeostasis of tissues, such as the myocardium. In this review, we will address the relevance of mitomiRs in cardiovascular pathologies by dissecting and categorizing their effect in mitochondrial function in order to provide a robust framework for new mitomiR-based therapeutical approaches to this group of diseases.

Keywords: Cardiovascular diseases; MiRNAs; Mitochondria; MitomiR.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / therapy
  • Humans
  • MicroRNAs* / genetics
  • Mitochondria / genetics
  • RNA, Messenger
  • RNA, Untranslated

Substances

  • MicroRNAs
  • RNA, Untranslated
  • RNA, Messenger